Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Titel:
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Auteur:
Bissler, John J Kingswood, J Christopher Radzikowska, Elżbieta Zonnenberg, Bernard A Frost, Michael Belousova, Elena Sauter, Matthias Nonomura, Norio Brakemeier, Susanne de Vries, Petrus J Whittemore, Vicky H Chen, David Sahmoud, Tarek Shah, Gaurav Lincy, Jeremie Lebwohl, David Budde, Klemens